Hereditary non-polyposis colorectal cancer syndrome – Life with Disease

Go back

Hereditary non-polyposis colorectal cancer syndrome is a condition passed down through families that significantly raises the risk of developing certain cancers, especially colorectal and endometrial cancer, often at a younger age than usual.

Understanding Your Outlook After Diagnosis

Learning that you have hereditary non-polyposis colorectal cancer syndrome, commonly called Lynch syndrome, can feel overwhelming. It’s important to understand that while this condition increases your cancer risk, it doesn’t mean you will definitely develop cancer. Many people with Lynch syndrome live full, healthy lives, especially when they follow regular screening schedules and work closely with their healthcare team.[1]

The chances of developing cancer vary depending on which gene is affected. People with mutations in the MLH1 or MSH2 genes tend to have a higher lifetime risk of colorectal cancer—somewhere between 50% and 80%—compared to those with mutations in MSH6 or PMS2 genes, where the risk is lower. Women with Lynch syndrome face an additional challenge, as they have between a 25% and 60% lifetime risk of developing endometrial cancer, making it the second most common cancer in this syndrome.[2][5]

When cancer does develop in people with Lynch syndrome, it typically appears earlier than in the general population. The average age of colorectal cancer diagnosis is around 44 years old, rather than in the 60s or 70s as is more common in sporadic cases. This earlier onset is one of the defining features of the syndrome and explains why screening recommendations begin much younger for people with Lynch syndrome.[5]

The good news is that early detection through regular surveillance significantly improves outcomes. When colorectal cancer is caught early through colonoscopy screening, treatment is much more likely to be successful. Many healthcare providers recommend starting colonoscopy screenings between ages 20 and 25, or 10 years younger than the youngest family member’s diagnosis, whichever comes first. This proactive approach allows doctors to find and remove precancerous polyps or detect cancer when it’s still small and more treatable.[1][15]

It’s also worth noting that survival rates and long-term prognosis depend heavily on how closely you follow screening recommendations and how quickly any cancers are detected. People who maintain regular surveillance tend to have better outcomes because problems are caught before they become serious. Your healthcare team will create a personalized screening schedule based on your specific gene mutation and family history.[18]

How the Condition Develops Without Treatment

Lynch syndrome is caused by inherited mutations in genes that normally help repair mistakes in DNA when cells divide. These genes—MLH1, MSH2, MSH6, PMS2, and sometimes EPCAM—work like a proofreading system for your genetic code. When these genes don’t work properly, errors in DNA accumulate over time, and some of these errors can eventually lead normal cells to become cancerous.[1][6]

Without regular screening and monitoring, the condition follows a natural course where the risk of cancer development increases as you age. Unlike some other inherited colorectal cancer conditions, Lynch syndrome typically doesn’t cause hundreds or thousands of polyps to form in the colon. Instead, people with this syndrome may develop polyps at a younger age than average, and these polyps are more likely to turn into cancer if not removed.[1]

The process from a healthy colon to cancer can take several years, which is why regular colonoscopy screening is so important. During these screenings, doctors can spot and remove polyps before they have a chance to become cancerous. Without this intervention, polyps can grow and transform into cancer, which may then spread to nearby tissues or other parts of the body if left untreated for too long.[15]

Beyond the colon, other organs are also at risk. In women, the lining of the uterus becomes increasingly vulnerable to abnormal cell growth that can develop into endometrial cancer. The stomach, small intestine, ovaries, urinary tract, pancreas, and other organs also face elevated cancer risk, though the degree of risk varies depending on which specific gene is mutated.[2][4]

⚠️ Important
Lynch syndrome is not contagious and cannot be passed from person to person through contact. However, the gene mutation can be inherited from a parent. If you have Lynch syndrome, each of your children has a 50% chance of inheriting the same mutation. This makes genetic counseling important not just for you, but for your entire family.

Possible Complications That May Arise

One of the most concerning complications of Lynch syndrome is the development of multiple primary cancers over a lifetime. This means someone might develop colorectal cancer first, and then years later develop a completely separate cancer in another organ, such as the endometrium, stomach, or ovaries. About 30% of people with Lynch syndrome who develop endometrial cancer are diagnosed with it before any colorectal cancer appears, making it an important sentinel condition to watch for.[5]

When colorectal cancer does develop, there’s also a risk of metachronous cancers—meaning a second colorectal cancer can develop in a different part of the colon even after the first one has been treated. This risk can be as high as 40% within 10 years after the first diagnosis if the entire colon isn’t removed during initial surgery. This is why doctors often recommend more extensive surgical procedures for people with Lynch syndrome compared to those with sporadic colorectal cancer.[12]

Surgery itself, while often necessary, can bring complications. Removing the entire colon (total colectomy) or most of it (subtotal colectomy) changes how your digestive system works. People who undergo these procedures may experience more frequent bowel movements, changes in stool consistency, or difficulty absorbing certain nutrients. Quality of life considerations are important when deciding between different surgical approaches, and your healthcare team should discuss these trade-offs with you thoroughly.[12]

Another complication involves the psychological burden of uncertainty. Living with the knowledge that you have an elevated cancer risk can cause significant anxiety and stress. Some people experience what’s called “genetic burden”—a heavy emotional weight from knowing they carry a mutation that not only affects their health but could also have been passed to their children. This psychological impact is real and should not be minimized.[19][23]

For women with Lynch syndrome, complications can also arise from the difficult decision about whether to undergo preventive removal of the uterus and ovaries (hysterectomy and bilateral salpingo-oophorectomy). While these surgeries can significantly reduce cancer risk, they also mean immediate surgical menopause for women who haven’t yet gone through natural menopause, bringing symptoms like hot flashes, mood changes, and impacts on bone health and cardiovascular risk.[2]

Impact on Daily Life and Activities

Living with Lynch syndrome affects many aspects of daily life beyond just medical appointments. The condition requires a significant time commitment for regular screening and surveillance. Depending on your specific mutation and personal history, you may need colonoscopies every one to two years, annual gynecological examinations with endometrial sampling for women, and potentially other screenings for stomach, urinary tract, or skin cancers. These appointments can take time away from work, family, and personal activities.[7]

The emotional and psychological impact can be substantial. Many people with Lynch syndrome describe living with a constant sense of uncertainty and vulnerability. You might find yourself analyzing every new symptom, wondering if it could be cancer. Some people experience what’s called “cancer worry” or health anxiety, where concern about developing cancer interferes with their ability to enjoy life fully. This emotional burden can affect relationships, career decisions, and overall quality of life.[19][23]

Social situations can become complicated as well. Deciding when and how to tell friends, partners, or extended family about your Lynch syndrome diagnosis isn’t always easy. Some people worry about being treated differently or facing discrimination in employment or insurance. Others struggle with guilt about potentially passing the mutation to their children. These concerns are valid and can create significant emotional distress that affects daily functioning.[19]

On the practical side, Lynch syndrome may influence major life decisions. Some people choose to complete their families earlier or decide against having biological children altogether due to concerns about passing on the mutation. Career choices might be affected by the need for good health insurance or flexible time off for medical appointments. Moving to a new city might require finding new healthcare providers who understand Lynch syndrome and can provide appropriate care.[21]

Physical activity and lifestyle modifications can play an important role in managing Lynch syndrome, but they also require commitment and sometimes lifestyle changes. While no specific diet or exercise program has been proven to prevent cancer in people with Lynch syndrome, maintaining a healthy lifestyle may help reduce overall cancer risk. Some people find that taking daily aspirin helps reduce their colorectal cancer risk, but this requires consistency and comes with its own considerations, such as increased bleeding risk.[21]

If you do develop cancer, the impact on daily life intensifies. Treatment with surgery, chemotherapy, or immunotherapy brings its own challenges, from managing side effects to taking time off work for recovery. Even after successful treatment, the fear of recurrence or developing a second cancer can be overwhelming. Many people find that cancer survivorship becomes an ongoing part of their identity and daily experience.[1]

⚠️ Important
Finding support from others who understand what you’re going through can make a significant difference. Many people with Lynch syndrome benefit from connecting with support groups, either online or in person, where they can share experiences and coping strategies. Professional counseling can also help you manage anxiety and make informed decisions about your health care.

Supporting Family Members Through Clinical Trials

When someone in your family has Lynch syndrome, understanding clinical trials becomes important because these studies may offer access to new screening methods, preventive treatments, or cancer therapies specifically designed for people with inherited cancer syndromes. Clinical trials are research studies that test whether new medical approaches are safe and effective. For Lynch syndrome families, participating in research can sometimes provide cutting-edge care while also contributing to scientific knowledge that helps future generations.[7]

Family members can play a crucial role in helping a loved one explore clinical trial options. Start by learning what clinical trials are available for Lynch syndrome. Major cancer centers and research institutions often have trials specifically for people with hereditary cancer syndromes. These might test new surveillance technologies, preventive medications, or treatments that work particularly well for cancers with the genetic characteristics seen in Lynch syndrome.[2]

Helping your family member prepare for potential trial participation can be very valuable. This might involve organizing medical records, gathering detailed family cancer history information, and making sure genetic testing results are readily available. Clinical trials often have specific requirements about what genetic mutations they’re studying, so having this documentation ready can speed up the screening process. You can also help research which trials might be a good fit based on your loved one’s specific situation.[7]

Emotional support is equally important. Making decisions about clinical trial participation can be stressful and confusing. Your family member may worry about receiving experimental treatments or not getting the standard care they would otherwise receive. As a supportive relative, you can help them understand that most trials are designed to be at least as good as standard care, and many provide additional monitoring and attention that can be beneficial. Attending appointments with them can help ensure they understand all the information being presented.[19]

Transportation and logistical support shouldn’t be overlooked. Clinical trials may require more frequent visits to the medical center than standard care, especially during the early phases. Family members can help by providing rides to appointments, helping manage medication schedules, or simply being present during visits to provide moral support and help remember important information from discussions with the research team.[19]

It’s also important for families to understand that participating in a clinical trial is always voluntary, and patients can withdraw at any time without affecting their access to standard care. Sometimes well-meaning family members can put pressure on a patient to participate in research when they’re not comfortable doing so. Supporting your loved one means respecting their decisions about their own healthcare, even if you might make different choices yourself.[7]

Communication within the family becomes especially important when considering clinical trials. If one family member has Lynch syndrome, others may too. Information learned through one person’s participation in research might be valuable for other family members to know about. Creating an open, supportive family environment where people feel comfortable sharing health information can benefit everyone’s long-term health outcomes.[6]

💊 Registered drugs used for this disease

Based on the available sources, no specific registered drugs are explicitly mentioned for hereditary non-polyposis colorectal cancer syndrome. However, the sources indicate that treatment approaches may include:

  • Chemotherapy – Used when colorectal cancer has spread beyond the colon to destroy cancer cells throughout the body
  • Immunotherapy – Preferred treatment option for metastatic colorectal cancer in Lynch syndrome patients, often more effective with fewer side effects than chemotherapy
  • Aspirin (for prevention) – Daily aspirin may help reduce colorectal cancer risk in people with Lynch syndrome, though this is a preventive measure rather than a treatment for existing cancer

Ongoing Clinical Trials on Hereditary non-polyposis colorectal cancer syndrome

  • Study on Mesalamine to Prevent Colorectal Cancer in Patients with Lynch Syndrome

    Recruiting

    1 1
    Investigated drugs:
    Denmark Sweden
  • Study on the Effect of Low-Dose Aspirin in Preventing New or Recurrent Colorectal Polyps in Patients with Lynch Syndrome

    Not recruiting

    1 1 1
    Investigated drugs:
    France

References

https://my.clevelandclinic.org/health/diseases/17097-hereditary-non-polyposis-colorectal-cancer-hnpcc

https://www.ncbi.nlm.nih.gov/books/NBK564511/

https://www.mayoclinic.org/diseases-conditions/lynch-syndrome/symptoms-causes/syc-20374714

https://medlineplus.gov/genetics/condition/lynch-syndrome/

https://en.wikipedia.org/wiki/Hereditary_nonpolyposis_colorectal_cancer

https://www.cdc.gov/colorectal-cancer-hereditary/about/lynch-syndrome.html

https://arupconsult.com/content/lynch-syndrome

https://staging.fascrs.org/patients/diseases-and-conditions/a-z/hereditary-colorectal-cancer

https://emedicine.medscape.com/article/188613-overview

https://my.clevelandclinic.org/health/diseases/17097-hereditary-non-polyposis-colorectal-cancer-hnpcc

https://www.ncbi.nlm.nih.gov/books/NBK431096/

https://emedicine.medscape.com/article/188613-treatment

https://nyulangone.org/conditions/colorectal-cancer/treatments/preventive-treatment-for-people-at-high-risk-for-colorectal-cancer

https://www.mayoclinic.org/diseases-conditions/lynch-syndrome/symptoms-causes/syc-20374714

https://uihc.org/health-topics/hereditary-colon-cancer-syndromes

https://arupconsult.com/content/lynch-syndrome

https://my.clevelandclinic.org/health/diseases/17097-hereditary-non-polyposis-colorectal-cancer-hnpcc

https://www.ncbi.nlm.nih.gov/books/NBK431096/

https://www.mdanderson.org/cancerwise/my-advice-for-coping-with-lynch-syndrome.h00-159222567.html

https://www.mayoclinic.org/diseases-conditions/lynch-syndrome/symptoms-causes/syc-20374714

https://pmc.ncbi.nlm.nih.gov/articles/PMC8364762/

https://www.foxchase.org/blog/5-things-know-about-lynch-syndrome

https://www.curetoday.com/view/living-with-lynch-syndrome-and-its-uncertainty

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

Is Lynch syndrome the same as having colon polyps?

No, Lynch syndrome is different from conditions that cause numerous polyps. People with Lynch syndrome typically don’t develop hundreds of polyps like those with familial adenomatous polyposis (FAP). Instead, they may develop polyps at a younger age, and these polyps have a higher chance of becoming cancerous if not removed.

If my parent has Lynch syndrome, will I definitely get it too?

No, it’s not guaranteed. Each child of a parent with Lynch syndrome has a 50% chance of inheriting the gene mutation. This means some children will inherit it while others won’t. Genetic testing can determine whether you’ve inherited the mutation from your parent.

What age should I start getting screened if I have Lynch syndrome?

Most healthcare providers recommend starting colonoscopy screenings between ages 20 and 25, or 10 years younger than the youngest family member who was diagnosed with cancer, whichever comes first. For women, gynecological screening for endometrial cancer typically begins in the mid-30s to early 40s, though your doctor will personalize recommendations based on your specific gene mutation.

Can I prevent cancer if I have Lynch syndrome?

While you cannot eliminate your cancer risk completely, you can significantly reduce it through regular surveillance screening, which catches cancer early when it’s most treatable. Some people choose preventive surgeries, such as removing the colon or uterus and ovaries. Daily aspirin may also help reduce colorectal cancer risk, though you should discuss this with your doctor as it has its own risks.

Which cancers are associated with Lynch syndrome besides colorectal cancer?

Lynch syndrome increases risk for several cancers including endometrial (uterine), ovarian, stomach, small intestine, urinary tract (kidney, ureter, bladder), pancreatic, prostate, brain, bile duct, gallbladder, and certain skin cancers. The risk level varies depending on which specific gene is mutated and whether you’re male or female.

🎯 Key takeaways

  • Lynch syndrome accounts for only 2-4% of all colorectal cancers but is the most common inherited form of the disease
  • People with Lynch syndrome develop colorectal cancer at an average age of 44, much younger than the general population
  • Each child of someone with Lynch syndrome has exactly a 50-50 chance of inheriting the mutation
  • Regular colonoscopy screening should start between ages 20-25 for those with Lynch syndrome, not at age 45 like the general population
  • Endometrial cancer is the second most common cancer in Lynch syndrome, affecting 25-60% of women with the condition
  • Immunotherapy often works better than chemotherapy for Lynch syndrome-related cancers with fewer side effects
  • The specific gene that’s mutated (MLH1, MSH2, MSH6, or PMS2) significantly affects both cancer risk level and which cancers are most likely
  • Having Lynch syndrome doesn’t guarantee you’ll develop cancer, but proactive surveillance dramatically improves outcomes when cancer does occur

Connected medications: